Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

Organigram Positioned for Substantial Growth from Edible Marijuana Products

Oct 10, 2017 • 12:54 PM EDT
Canada Stocks (60).png
3 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

MONCTON, New Brunswick, Oct. 10, 2017 (GLOBE NEWSWIRE) — One of Canada’s leading medical marijuana producers says it is ready to take advantage of the sale of cannabis edibles and concentrates.

Organigram Holdings Inc. (TSX-V:OGI) (OTCQB:OGRMF) (the “Company” or “Organigram”) says the recent announcement that the federal government will likely approve the production and sale of edibles for the recreational market will give it opportunities for rapid growth.  “We have the infrastructure and capabilities in place to produce significant quantities of edible and concentrate based products,” said Greg Engel, CEO, Organigram. “This means we will be able to diversify our product offerings providing consumers with a wide-range of traditional and new product choices when they are approved for use,” he said.

Engel said Organigram anticipated the evolution of the recreational marijuana market would eventually include edibles and concentrates.  To ensure Organigram would be ready for the market growth from edibles, the company entered into an exclusive agreement last year with TGS Colorado (TGS), a vertically integrated seed-to-sale conglomerate generally regarded as having the best-in-class technological expertise in extract technology. This arrangement focuses on leveraging TGS’s product development knowledge and provides exclusive Canadian access to industry-leading intellectual property, technology, engineering, retail design, product formulations and packaging. “This strategic partnership certainly gives Organigram a significant competitive advantage in the developing Canadian market,” said Engel.

TGS operates over 300,000 sq. ft. of indoor production space, 16,000 sq. ft. of greenhouse, 25 acres of outdoor production and 14 retail locations across Colorado.  The company also has operations in four other US states. TGS sells over 400 regulated products through its retail operations in Colorado. (The entire TGS product catalogue is available to view here.)  With access to this impressive product portfolio, Organigram has been working with TGS closely on preparations for the Canadian market for over a year.

 “Our working relationship with TGS means we are able to bring products to market quicker than others who don’t have this level of infrastructure in place,” said Ray Gracewood, Organigram’s Chief Commercial Officer.

Investment in technology allows for product innovation

Engel also noted that Organigram has invested heavily in its own operations.  We expect to commission the company’s industrial scale CO2Supercritical Fluid Extraction (SFE) System this week. CO2 extraction provides the highest-quality extract for edibles and extract product manufacturing and will significantly increase Organigram’s extraction capacity in preparation for the adult recreational market. The new unit has the highest processing capacity of any CO2 extraction system currently in use in Canada for marijuana extraction. Using the new technology, Organigram’s Moncton operation will be able to process a minimum of 5,000 kilograms of starting material annually with a single day shift five days a week.  The processed concentrate and edible products will have a potential retail market value of between $40 and $50 million annually.

 “When you pair a best-in-class team with best-in-class tools, you can’t help but discover new and exciting ways to re-imagine our products and industry,” said Engel. “Having this kind of equipment in-house means we are able to continue fostering an environment of innovation and leadership.

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.